Pompe Disease Treatment Market is Projected to Register a Healthy CAGR of 8.81%

Posted by nileshdbmr on April 13th, 2021

pompe disease treatment market is rising gradually with a substantial CAGR of 8.81% in the forecast period of 2020-2026.Pompe disease is a genetic disorder that is caused by the buildup of a complex sugar called glycogen in cells and tissues. This accumulation of glycogen causes impairment in organs and tissues.

This disease majorly causes muscle wasting, muscle weakness and other complications such as cardiac problems and respiratory disorders. GAA gene is responsible for breakdown of glycogen in the body. In Pompe disease, mutation occurs in GAA gene that results in accumulation of glycogen in tissues and organs.

Get Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-pompe-disease-treatment-market

Key Market Players:

Few of the major competitors currently working in the global pompe disease treatment market are Amicus Therapeutics, Inc., Takeda Pharmaceutical Company, Sanofi,, Valerion Therapeutics, Sangamo Therapeutics, Oxyrane, EpiVax, Inc., Alexion Pharmaceuticals, Inc., Novartis AG, GlaxoSmithKline plc., Audentes Therapeutics, Spark Therapeutics, Inc., Pfizer Inc., BioMarin, ABIOMED, Sarepta Therapeutics,. Biogen, Genentech, Inc., among others.

Segmentation: Global Pompe Disease Treatment Market

•          By Type (Classic Infantile-Onset Pompe Disease, Non-Classic Infantile-Onset Pompe Disease, Late-Onset Pompe Disease)
•          By Therapy Type (Medication, Enzyme Replacement Therapy, Physiotherapy, Others)
•          By Route of Administration (Oral, Injectable, Others)
•          By End Users (Hospitals, Homecare, Specialty Clinics, Others)
•          By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others)
•          By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)

Competitive Analysis:

Global pompe disease treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Pompe disease treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Market Drivers

•          Advancement in the gene therapy and enzyme replacement therapies also acts as a market driver
•          Rising healthcare infrastructure for Pompe disease drugs will expand the market size
•          Increasing research and development for effective treatments and diagnosis technologies for Pompe disease is another factor boosting the market growth
•          Rising prevalence rate of people suffering from Pompe disease is expected to drive the market growth in the forecast period